Results 1 to 10 of about 4,612,830 (320)

Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke [PDF]

open access: yesJournal of Stroke, 2013
Background and PurposeWidespread use of thrombolytic treatments, along with improved chances of survival after an initial ischemic stroke, increases the possibility of repeated thrombolysis. There are few reports, however, regarding repeated thrombolysis
Han Soo Yoo   +9 more
doaj   +2 more sources

Application and risk prediction of thrombolytic therapy in cardio-cerebrovascular diseases: a review [PDF]

open access: yesThrombosis Journal, 2023
Cardiocerebrovascular diseases (CVDs) are the leading cause of death worldwide, consuming huge healthcare budget. For CVD patients, the prompt assessment and appropriate administration is the crux to save life and improve prognosis. Thrombolytic therapy,
Kexin Zhang   +3 more
doaj   +2 more sources

Knowledge of thrombolytic therapy for acute ischemic stroke among community residents in western urban China. [PDF]

open access: yesPLoS ONE, 2014
Thrombolytic therapy rate for acute ischemic stroke remains low, and improving public awareness of thrombolytic therapy may be helpful to reduce delay and increase chances of thrombolytic therapy.
Juan Yang   +7 more
doaj   +1 more source

The Effect of The Thrombolytic Treatment on Inflammatory Markers in Male Patients with Pulmonary Thromboembolism

open access: yesSakarya Tıp Dergisi, 2021
Objective: Neutrophil to lymphocyte (NLR) and platelet to lymphocyte (PLR) ratios play an important role in monitoring the progression of the disease and determining the course of the disease in patients with acute pulmonary thromboembolism (APTE).
Ayhan Coşgun, Hüseyin Ören
doaj   +1 more source

Case report of repeat thrombolytic therapy in patient with acute circular-apical myocardial infarction, complicated anginous status

open access: yesЕвразийский Кардиологический Журнал, 2023
Presented clinical case report illustrates nonstandart approach use repeat thrombolytic therapy patient 49 y.o. with acute circular – apical myocardial infarction, after noneffective primary systemic thrombolytic therapy rtPA.
D. V. Bosikov   +3 more
doaj   +1 more source

Outcome of sub-massive pulmonary thromboemboli in patients who received thrombolytic and or non-thrombolytic therapy

open access: yesResearch in Cardiovascular Medicine, 2016
Background: Thrombolytic therapy in patients with sub-massive pulmonaryembolism (SMPTE) needs further assessment. Objectives: The current study aimed to assess a potential benefit of thrombolytic and non-thrombolytic therapy in patients with SMPTE ...
Hasan Allah Sadeghi   +4 more
doaj   +1 more source

Tratamento trombolítico do enfarte agudo do miocárdio. Primeira de três partes.

open access: yesActa Médica Portuguesa, 1998
I-Rationale of thrombolytic therapy in acute myocardial infarction (AMI). II-Thrombolytic drugs. III-Effects of thrombolytic therapy on mortality. IV-Studies comparing the effects of various thrombolytic agents on mortality.
J T Soares-Costa   +2 more
doaj   +1 more source

Spectrophotometric analysis of thrombolytic activity: SATA assay [PDF]

open access: yes, 2017
Introduction: Measurement of thrombolytic activity i.e. clot lysis is crucial for research and development of novel thrombolytics. It is also a key factor in assessment of the effectiveness of conventionally used thrombolytic agents in the clinic, which ...
Entekhabi, Nazila   +5 more
core   +2 more sources

Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis [PDF]

open access: yes, 2007
Background: Meta-analyses of trials have shown greater benefits from angioplasty than thrombolysis after an acute myocardial infarction, but the time delay in initiating angioplasty needs to be considered.
Abrams, Keith R.   +6 more
core   +4 more sources

Home - About - Disclaimer - Privacy